KALA BIO
IPOPublic · Arlington, United States · $113.2M raised
- Headquarters
- Arlington, Massachusetts
- Employees
- 1–10
- Business Model
- B2B
- Website
- kalarx.com
- Total Funding
- $113.2M
- Last Round
- $68.0M Series CApr 2016
- Rounds
- 4
- Type
- Public
About
KALA BIO is a clinical-stage biopharmaceutical company focused on developing treatments for rare and serious eye diseases.
Summary
KALA BIO is a Biotech company based in Arlington, United States. It has raised $113.2M in total across 4 rounds, most recently a $68.0M Series C round in Apr 2016. Investors include OrbiMed, Ysios Capital and Third Rock Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jul 2017
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...